Hollsteen
← Celestica

Equity incl. NCI

Balance – as of period end · $M

QuartersFiscal years

$MEquity incl. NCI · Q1 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 2021: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2021: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2021: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2021: $1.5B · 10-K 0001030894-25-000014 filed Mar 3, 2025Equity incl. NCI · Q1 2022: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2022: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2022: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2022: $1.7B · 10-K 0001030894-25-000014 filed Mar 3, 2025Equity incl. NCI · Q1 2023: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2023: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2023: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2023: $1.8B · 10-K 0001030894-25-000014 filed Mar 3, 2025Equity incl. NCI · Q1 2024: $1.7B · 10-Q 0001030894-25-000028 filed Apr 24, 2025Equity incl. NCI · Q2 2024: $1.8B · 10-Q 0001030894-25-000047 filed Jul 28, 2025Equity incl. NCI · Q3 2024: $1.8B · 10-Q 0001030894-25-000053 filed Oct 27, 2025Equity incl. NCI · Q4 2024: $1.9B · 10-K 0001030894-25-000014 filed Mar 3, 2025Equity incl. NCI · Q1 2025: $1.6B · 10-Q 0001030894-25-000028 filed Apr 24, 2025Equity incl. NCI · Q2 2025: $1.8B · 10-Q 0001030894-25-000047 filed Jul 28, 2025Equity incl. NCI · Q3 2025: $2.0B · 10-Q 0001030894-25-000053 filed Oct 27, 2025Equity incl. NCI · Q4 2025: $2.2B · 10-K 0001030894-26-000011 filed Feb 27, 2026Equity incl. NCI · Q1 2026: $2.1B · 10-Q 0001030894-26-000032 filed Apr 27, 2026Equity incl. NCI · Q2 2026: $2.5B · 10-Q 0001030894-26-000044 filed Jul 27, 2026missing2,2162,4801,462Q1 2016Q2 2026
$MEquity incl. NCI · Q3 2024: $1.8B · 10-Q 0001030894-25-000053 filed Oct 27, 2025Equity incl. NCI · Q4 2024: $1.9B · 10-K 0001030894-25-000014 filed Mar 3, 2025Equity incl. NCI · Q1 2025: $1.6B · 10-Q 0001030894-25-000028 filed Apr 24, 2025Equity incl. NCI · Q2 2025: $1.8B · 10-Q 0001030894-25-000047 filed Jul 28, 2025Equity incl. NCI · Q3 2025: $2.0B · 10-Q 0001030894-25-000053 filed Oct 27, 2025Equity incl. NCI · Q4 2025: $2.2B · 10-K 0001030894-26-000011 filed Feb 27, 2026Equity incl. NCI · Q1 2026: $2.1B · 10-Q 0001030894-26-000032 filed Apr 27, 2026Equity incl. NCI · Q2 2026: $2.5B · 10-Q 0001030894-26-000044 filed Jul 27, 20262,2162,4801,814Q3 2024Q2 2026Q4 2025
Q4 2025
2,216$M
All values (13)
PeriodValue ($M)Status
Q2 20262,480reported
Q1 20262,098reported
Q4 20252,216reported
Q3 20252,029reported
Q2 20251,758reported
Q1 20251,557reported
Q4 20241,896reported
Q3 20241,814reported
Q2 20241,799reported
Q1 20241,709reported
Q4 20231,771reported
Q1 2023 – Q3 2023–missing (3 periods): No verified SEC value extracted, although the company reports this metric in other periods.
Q4 20221,676reported
Q1 2022 – Q3 2022–missing (3 periods): Grund wie bei Q1 2023 – Q3 2023.
Q4 2021Noneerror
Q1 2016 – Q3 2021–missing (23 periods): Grund wie bei Q1 2023 – Q3 2023.

Show reported periods only · CSV with all sources · Technical ID: equity_total

More metrics for Celestica

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Operating income by segment

Sources & calculation
Value
$2.2B
Period
Q4 2025, ended Dec 31, 2025 · as of Dec 31, 2025 (balance as of date, not a sum)
Source
10-K, filed Feb 27, 2026 · 0001030894-26-000011
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$2.2BFeb 27, 202610-K 0001030894-26-000011reported · confidence 1. · current